risedronic acid has been researched along with Erythema Multiforme in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia-Nunez, I | 1 |
| Algaba-Marmol, MA | 1 |
| Castro-Cost, C | 1 |
| Bianchi, L | 1 |
| Hansel, K | 1 |
| Romita, P | 1 |
| Foti, C | 1 |
| Stingeni, L | 1 |
2 other studies available for risedronic acid and Erythema Multiforme
| Article | Year |
|---|---|
Erythema Multiforme After Intake of Risedronate: A Cross-Reactivity Study.
Topics: Drug Administration Schedule; Erythema Multiforme; Humans; Risedronic Acid | 2021 |
Erythema multiforme-like eruption induced by risedronate.
Topics: Bone Density Conservation Agents; Drug Eruptions; Erythema Multiforme; Female; Humans; Middle Aged; | 2017 |